Käyttötarkoitus dopingaineena
Haittavaikutukset
[1] de Ronde W, de Jong F. Aromatase inhibitors in men: effects and therapeutic options. Rerod Biol Endocrinol. 2011; 9:93
[2] Duodecim lääketietokanta. 2019. Aromataasin estäjät. Terveysportti
[3] Schlegel P. Aromatase inhibitors for male infertility. Fertility and Sterility. 2012; 98(6): 1359–1362
[4] Mauras N, Ross J, Gagliardi P, Yu M, Hossain J, Permuy J, Damaso L, Merinbaum D, Sing R, Gaete X, Mericq V. Randomized trial of aromatase inhibitors, growth hormone, or combination in pubertal boys with idiopathic, short stature. JCEM. 2016;101(12):4984–4993
[5] Ring J, Lwin A, Köhler T. Current medical management of endocrine-related male infertility. Asian J Androl. 2016:18(3):357–363
[6] William M, Bartlett J, Brodie A, Brueggemeier R, di Salle E, Lønning P, Llombart A, Maass N, Maudelonde T, Sasano H, Gossa P. Aromatase inhibitors: Are there differences between steroidal and nonsteroidal aromatase inhibitors and do they matter? Oncologist. 2008;13(8):829–37
[7] Nieschlag E, Vorona E. Mechanisms in Endocrinology: Medical Consequences of Doping With Anabolic Androgenic Steroids: Effects on Reproductive Functions. Eur J Endocrinol. 2015;173(2): R47–58
[8] Handelsman D. Indirect androgen doping by oestrogen blockade in sports. Br J Pharmacol. 2008;154(3):598–605
[9] Loves S, Ruinemans-Koerts J, de Boer H. Letrozole once a week normalizes serum testosterone in obesity-related male hypogonadism. Eur J Endocrinol. 2008;158(5):747–7
[10] Khosla S, Melton J, Riggs L. Estrogen and the male skeleton. J Clin Endo Metab. 2002;87(4):1443–1450
[11] Vanderschueren D, Laurent M, Claessens F, Gielen E, Lagerquist M, Vandenput L, Börjesson A, Ohlsson C. Sex steroid actions in male bone. Endocr Rev. 2014;35(6):906-960
[12] Wang X, Zhu A, Wang J, Ma F, Liu J, Fan Y, Luo Y, Zhang P, Li Q, Xu B, Yuam P. Steroidal aromatase inhibitors have a more favorable effect on lipid profiles than nonsteroidal aromatase inhibitors in postmenopausal women with early breast cancer: a prospective study. Ther Adv Med Oncol. 2020;12:1758835920925991